Regarding the mechanism, ATO promoted autophagic degradation of EGFR in NSCLC cells by directly binding to P62, which interacted with EGFR, and preferentially the L858R/T790M mutant, providing an explanation for the more favorable effect of ATO on gefitinib-resistant cells [21]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.